Last reviewed · How we verify
Baseline Treatment
Baseline treatment is a type of therapy that aims to establish a standard level of treatment for a particular disease or condition.
Baseline treatment is a type of therapy that aims to establish a standard level of treatment for a particular disease or condition. Used for Metastatic non-small cell lung cancer.
At a glance
| Generic name | Baseline Treatment |
|---|---|
| Sponsor | Hoffmann-La Roche |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
Baseline treatment is used to establish a reference point for measuring the effectiveness of new treatments. It is typically a well-established therapy that has been shown to be effective in managing a particular disease or condition.
Approved indications
- Metastatic non-small cell lung cancer
Common side effects
- Fatigue
- Nausea
- Vomiting
Key clinical trials
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer (PHASE2)
- A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations (PHASE2)
- Reducing Symptom Burden Through Physical Exercise in Melanoma Patients (NA)
- MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease (NA)
- A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma (PHASE3)
- Assisted Identification and Navigation of Early Mental Health Symptoms in Children (NA)
- IC14 for Treatment of Acute Decompensated Heart Failure (PHASE1, PHASE2)
- Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Baseline Treatment CI brief — competitive landscape report
- Baseline Treatment updates RSS · CI watch RSS
- Hoffmann-La Roche portfolio CI